MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis

J Cell Biol. 2007 Dec 17;179(6):1219-30. doi: 10.1083/jcb.200705046.

Abstract

Increasing evidence suggests that neurotoxicity of secreted superoxide dismutase 1 (SOD1) mutants is associated with amyotrophic lateral sclerosis (ALS). We show here that mutant SOD1 protein activates microglia via a myeloid differentiation factor 88 (MyD88)-dependent pathway. This inflammatory response is also associated with a marked recruitment of bone marrow-derived microglia (BMDM) in the central nervous system. We then generated chimeric SOD1(G37R) and SOD1(G93A) mice by transplantation of bone marrow (BM) cells from MyD88-deficient or green fluorescent protein (GFP)-expressing mice. SOD1(G37R) mice receiving MyD88(-/-) BM cells exhibit a significantly earlier disease onset and shorter lifespan compared with mice transplanted with control GFP cells. This compelling beneficial effect of MyD88-competent BMDM is a previously unrecognized natural innate immune mechanism of neuroprotection in a mouse model of late-onset motor neuron disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Amyotrophic Lateral Sclerosis / epidemiology
  • Amyotrophic Lateral Sclerosis / metabolism*
  • Animals
  • Axons / ultrastructure
  • Bone Marrow Cells / metabolism*
  • Bone Marrow Transplantation
  • Chimera / genetics
  • Chimera / metabolism
  • Disease Models, Animal
  • Female
  • Longevity
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microglia / metabolism
  • Motor Neurons / pathology
  • Myeloid Differentiation Factor 88 / metabolism*
  • Signal Transduction
  • Spinal Cord / pathology
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase-1

Substances

  • Myd88 protein, mouse
  • Myeloid Differentiation Factor 88
  • Sod1 protein, mouse
  • Superoxide Dismutase
  • Superoxide Dismutase-1